Form 4: Insulet EVP Michael Panos Receives Equity Grant

Insulet Corporation EVP and CCO Michael Panos was granted 2,777 restricted stock units and 7,255 stock options on April 1, 2026.

Summary

• Michael Panos, EVP and CCO of Insulet Corporation, received a grant of 2,777 restricted stock units (RSUs).
• The reporting person also received a grant of 7,255 non-qualified stock options with an exercise price of $207.04.
• The RSUs vest in equal installments over three years.
• The stock options vest in equal installments over four years and expire on April 1, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation practices.

Positives

• Equity-based compensation aligns the interests of the executive with long-term shareholder value.
• The multi-year vesting schedules for both RSUs and options encourage executive retention.

Negatives

• The issuance of new equity awards results in potential dilution for existing shareholders.

Risks

• Future share price volatility may impact the ultimate value realized by the executive from these grants.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive compensation.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the medical device industry to incentivize long-term strategic performance and retention.

Comparison to Industry Standards

• The use of a mix of RSUs and stock options is consistent with compensation structures at peer medical technology companies like DexCom and Tandem Diabetes Care.
• Vesting periods of 3-4 years are standard for executive equity awards in the healthcare sector.

Stakeholder Impact

• Shareholders may experience minor dilution from the issuance of these equity awards.

Next Steps

• Vesting of RSU installments on the first, second, and third anniversaries of the grant date.
• Vesting of option installments on the first, second, third, and fourth anniversaries of the grant date.

Key Dates

Keywords

Insulet, PODD, Form 4, Insider Trading, Executive Compensation, Stock Options, Restricted Stock Units